Community/Retail

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, discusses new trends pharmacists should know about atrial fibrillation management.

Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, demonstrates proper technique for inhaler devices.

Patients with severe asthma now have a new treatment option: reslizumab (Cinqair).

An act to restrict direct-to-consumer advertising was recently referred to the House Committee on Energy and Commerce.

The game-changing property of these antibiotics is their one-time dosing.

Did you know that gout has been recognized as a disease since 2640 BC?

Aralez Pharmaceuticals Inc resubmitted its new drug application to the FDA for its investigational candidate PA32540/PA8140 as secondary prevention of cardiovascular disease in patients at risk for aspirin-induced gastric ulcers.

Dennis Williams, PharmD, FAPhA, discusses the existing pharmacotherapy and immunotherapy options for managing allergic rhinitis.

Buprenorphine is now available in several dosage forms with various indications.

The FDA is requiring a new boxed warning for all immediate-release opioids that outlines the serious risks of opioid misuse, abuse, addiction, overdose, and death.

A recent ProPublica analysis found that physicians who receive payments from drug companies may exhibit different prescribing patterns with respect to brand-name medications.

The results of this year's pharmacy residency Match have been released, stirring up a range of emotions among applicants across the country.

Physicians and pharmacists usually work well together as part of a patient's care team, but there are some things that many physicians would prefer pharmacists not to know.

The possibilities for new human experience are limitless.

Vaccines are one of the greatest success stories in the history of public health, so why are deaths from vaccine-preventable diseases on the rise?

Hypertension strikes 90% of individuals in their lifetimes, causes 7.6 million premature deaths globally on an annual basis, and leads to a loss of 92 million disability-adjusted life years.

Kroger has announced the promotion of Michael Marx and Don Rosanova, who will serve as the presidents of Roundy's Supermarkets, Wisconsin, and Mariano's, respectively.

Levothyroxine is the most-prescribed generic drug in the world.

A pharmacist has been arrested for allegedly defrauding New York's Medicaid program by billing for high-cost HIV medications that were never actually dispensed.

Alzheimer's disease is the most common form of dementia in individuals older than 65 years and affects more than 5 million Americans.

Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, discusses adverse effects associated with asthma and COPD treatments.

Nearly 4000 pharmacy students recently matched with 1797 residency programs across the country.

National Community Pharmacists Association CEO B. Douglas Hoey, RPh, MBA, issued the following statement today in response to Senate passage of S. 483, the Ensuring Patient Access and Effective Drug Enforcement Act.

Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, professor and department chair for Pharmacy Practice, University of Mississippi School of Pharmacy, offers advice for how pharmacists can approach the delicate subject of weight-loss with patients.

Pharmacy Times' March Madness bracket combines sports and pharmacy.

Ever since the human papillomavirus vaccine hit the market 6 years ago, the prevalence of HPV has markedly decreased among women aged 14 to 24 years.

Pharmacists should double-check patients self-reporting allergies to ensure that they're taking accurate and appropriate treatment.

The FDA has approved obiltoxaximab (Anthim) injection to treat inhalational anthrax in combination with appropriate antibacterial medications.

The Meijer LPGA Classic for Simply Give has announced a three-day grand tasting event that Meijer will host in conjunction with the LPGA tournament week June 14-19.

The FDA has expanded the use of crizotinib, making it the first and only FDA-approved treatment for individuals with advanced non-small cell lung cancer whose tumors have an ROS-1 gene alteration.